Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020
Authors' conclusion
Our study found that there has been no significant change in the rates of osteoporosis screening or treatment within 1 year following PPF.
Study context
- Population
- Patients older than 40 with a lower extremity periprosthetic fracture 2010–2020 and no prior osteoporosis screening or treatment
- Outcome
- Trends (CAGR) in rates of bone mineral density (BMD) measurement by DXA, anti-osteoporotic pharmacotherapy, or either intervention after PPF, 2010–2020
- Follow-up
- Within 1 year following PPF
Methodological detailslarge national administrative database, linear regression of trends
- Large national administrative database
- Linear regression of trends
Main finding
As reported in the abstract
Screening (DXA), compounded annual growth rate (CAGR) (no significant change)
+ 0.1%
p = 0.13
Treatment, CAGR (no significant change)
- 2.4%
p = 0.29
Either intervention, CAGR (no significant change)
- 1.1%
p = 0.77
Observational data: associations, not effects.
Further findings
Overall rates of osteoporosis screening and treatment
- Screened for osteoporosis
- 5.7%
- Treated for osteoporosis
- 3.6%
Factors associated with intervention
- Older age, female sex, and increased comorbidities
Original publication
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020. Osteoporos Int. Published 15 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →